Abstract
Background The correlation between metabolic score for insulin resistance (METS-IR) and high insulin normal glucose clamp test is stronger than other non-insulin-based insulin resistance scores. Insulin resistance was related to the occurrence and development of hypertension and stroke, however, the association between METS-IR and hypertension, as well as ischemic stroke is lack of evidence. This study aimed to determine the association between METS-IR and acute ischemic stroke in non-diabetic patients, and the mediating role of blood pressure parameters on it.
Methods This hospital-based study included 557 non-diabetic subjects diagnosed with premature acute ischemic stroke. Logistic regression models and mediation analyses were conducted to assess the role of blood pressure parameters (systolic blood pressure, diastolic blood pressure, pulse pressure and mean arterial pressure) in the associations between METS-IR and risk of acute ischemic stroke.
Results After adjusting for potential covariates, each SD increment of METS-IR was associated with 26% higher odds (OR = 1.26, 95% CI: 1.06-1.52) increment in ORs of acute ischemic stroke. The OR for acute ischemic stroke in patients with highest quartile of METS-IR was 1.73 hold (OR = 1.73, 95% CI: 1.12-2.70) higher than that in those with the lowest quartile of METS-IR. Furthermore, mediation analyses indicated that pulse pressure partially mediate the detrimental effect of insulin resistance (assessed by the METS-IR) on acute ischemic stroke (mediation percentage: 11.70%).
Conclusions Our study suggests a relationship between METS-IR and acute ischemic stroke, and the association of METS-IR with acute ischemic stroke was partially mediated by pulse pressure.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
This study was approved by the Ethics Committee of the Second Affiliated Hospital of Xi'an Jiaotong University (Approval No. 2022200).
Funding Statement
This work was supported by the National Natural Science Foundation [grant numbers: 82103934].
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
All procedures performed in this study were in accordance with the ethical standards of the institution and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards. This study was approved by the Ethics Committee of the Second Affiliated Hospital of Xi'an Jiaotong University (Approval No. 2022200). The data are anonymous, and the requirement for informed consent was therefore waived.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data generated or analyzed during this study are included in this article. Further enquiries can be directed to the corresponding author
